AbbVie to buy Pharmacyclics in a $21 billion deal
The purchase would expand AbbVie's cancer drug portfolio.
Here’s how you can build the perfect workplace
The secret to attracting and holding on to the world's best talent isn't about the perks on offer — it's about relationships.
ECB to start buying government bonds
Draghi puts a smile on the bond market's face, but gives cold comfort to Greece.
The 100 best companies to work for
The 100 best companies to work for
What makes a company a great place to work? Is it the corporate culture, or the perks on offer? Find out which company ranked No.1 in this year’s list, and why.
Sign up for the Fortune Daily
AbbVie to buy Pharmacyclics in a $21 billion deal
The purchase would expand AbbVie's cancer drug portfolio.
Here’s how you can build the perfect workplace
The secret to attracting and holding on to the world's best talent isn't about the perks on offer — it's about relationships.
ECB to start buying government bonds
Draghi puts a smile on the bond market's face, but gives cold comfort to Greece.
Fortune 500 Companies in the News
Inside Apple: What it was like to pitch to Steve Jobs
"Are you smart? Are you going to waste my time?"
Wal-Mart, Starbucks, Aetna’s pay hikes: Why now?
More companies are worried about the fact that workers’ wages have been stagnant for decades. The recent spate of pay raises could be a response to such concerns.
By Erin Griffith
Etsy files for handcrafted IPO
The handcrafted marketplace cited losing its authenticity as a risk factor in its regulatory filing Wednesday.
By Daniel Roberts
5 leadership lessons from the new season of ‘Survivor’
After the first episode, the supposed leaders don't look so smart.